Vitrolife AB (publ) (VTRLY)
USD 19.8
(0.0%)
USD 19.8
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.51 Billion SEK | 8.6% |
| 2022 | 3.23 Billion SEK | 92.41% |
| 2021 | 1.68 Billion SEK | 34.94% |
| 2020 | 1.24 Billion SEK | -15.85% |
| 2019 | 1.48 Billion SEK | 28.56% |
| 2018 | 1.15 Billion SEK | 10.05% |
| 2017 | 1.04 Billion SEK | 22.21% |
| 2016 | 856.1 Million SEK | 18.51% |
| 2015 | 722.37 Million SEK | 41.5% |
| 2014 | 510.51 Million SEK | 12.76% |
| 2013 | 452.73 Million SEK | 25.06% |
| 2012 | 362.02 Million SEK | 1.66% |
| 2011 | 356.11 Million SEK | 19.68% |
| 2010 | 297.56 Million SEK | 8.35% |
| 2009 | 274.62 Million SEK | 21.98% |
| 2008 | 225.14 Million SEK | 19.16% |
| 2007 | 188.93 Million SEK | 10.32% |
| 2006 | 171.26 Million SEK | 42.58% |
| 2005 | 120.12 Million SEK | 15.66% |
| 2004 | 103.85 Million SEK | 7.89% |
| 2003 | 96.25 Million SEK | -6.8% |
| 2002 | 103.28 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 941 Million SEK | 11.89% |
| 2024 Q1 | 841 Million SEK | -6.97% |
| 2024 Q3 | 867 Million SEK | -7.86% |
| 2023 Q2 | 905 Million SEK | 5.97% |
| 2023 Q4 | 904 Million SEK | 6.6% |
| 2023 FY | 3.51 Billion SEK | 8.6% |
| 2023 Q1 | 854 Million SEK | -0.12% |
| 2023 Q3 | 848 Million SEK | -6.3% |
| 2022 Q2 | 829 Million SEK | 10.24% |
| 2022 Q1 | 752 Million SEK | 46.24% |
| 2022 Q4 | 855 Million SEK | 7.14% |
| 2022 Q3 | 798 Million SEK | -3.74% |
| 2022 FY | 3.23 Billion SEK | 92.41% |
| 2021 Q3 | 405.56 Million SEK | 6.16% |
| 2021 Q4 | 514.23 Million SEK | 26.79% |
| 2021 Q1 | 378.95 Million SEK | -0.9% |
| 2021 Q2 | 382.04 Million SEK | 0.82% |
| 2021 FY | 1.68 Billion SEK | 34.94% |
| 2020 FY | 1.24 Billion SEK | -15.85% |
| 2020 Q1 | 333.87 Million SEK | -18.47% |
| 2020 Q2 | 209.16 Million SEK | -37.35% |
| 2020 Q4 | 382.38 Million SEK | 19.44% |
| 2020 Q3 | 320.14 Million SEK | 53.06% |
| 2019 Q2 | 380.73 Million SEK | 22.06% |
| 2019 Q4 | 409.48 Million SEK | 8.33% |
| 2019 Q1 | 311.92 Million SEK | -2.56% |
| 2019 FY | 1.48 Billion SEK | 28.56% |
| 2019 Q3 | 377.99 Million SEK | -0.72% |
| 2018 Q3 | 284.01 Million SEK | 0.28% |
| 2018 Q4 | 320.11 Million SEK | 12.71% |
| 2018 Q1 | 263.99 Million SEK | -2.53% |
| 2018 FY | 1.15 Billion SEK | 10.05% |
| 2018 Q2 | 283.23 Million SEK | 7.29% |
| 2017 Q3 | 245.9 Million SEK | -13.83% |
| 2017 FY | 1.04 Billion SEK | 22.21% |
| 2017 Q4 | 270.84 Million SEK | 10.14% |
| 2017 Q2 | 285.38 Million SEK | 16.92% |
| 2017 Q1 | 244.08 Million SEK | -2.72% |
| 2016 Q2 | 207.77 Million SEK | 11.11% |
| 2016 Q4 | 250.9 Million SEK | 19.24% |
| 2016 FY | 856.1 Million SEK | 18.51% |
| 2016 Q1 | 186.99 Million SEK | -6.04% |
| 2016 Q3 | 210.42 Million SEK | 1.28% |
| 2015 Q1 | 162.39 Million SEK | 18.66% |
| 2015 Q3 | 176.8 Million SEK | -3.99% |
| 2015 Q2 | 184.14 Million SEK | 13.39% |
| 2015 Q4 | 199.02 Million SEK | 12.57% |
| 2015 FY | 722.37 Million SEK | 41.5% |
| 2014 Q3 | 125.14 Million SEK | -3.32% |
| 2014 Q2 | 129.43 Million SEK | 8.7% |
| 2014 Q4 | 136.85 Million SEK | 9.36% |
| 2014 Q1 | 119.07 Million SEK | -3.59% |
| 2014 FY | 510.51 Million SEK | 12.76% |
| 2013 Q4 | 123.5 Million SEK | 13.68% |
| 2013 FY | 452.73 Million SEK | 25.06% |
| 2013 Q1 | 104.6 Million SEK | 6.8% |
| 2013 Q2 | 115.99 Million SEK | 10.88% |
| 2013 Q3 | 108.64 Million SEK | -6.34% |
| 2012 Q1 | 99.72 Million SEK | 4.56% |
| 2012 Q3 | 82.92 Million SEK | -12.91% |
| 2012 Q2 | 95.22 Million SEK | -4.51% |
| 2012 Q4 | 97.94 Million SEK | 18.12% |
| 2012 FY | 362.02 Million SEK | 1.66% |
| 2011 FY | 356.11 Million SEK | 19.68% |
| 2011 Q1 | 88.03 Million SEK | 8.64% |
| 2011 Q4 | 95.37 Million SEK | 12.13% |
| 2011 Q3 | 85.05 Million SEK | -2.97% |
| 2011 Q2 | 87.65 Million SEK | -0.43% |
| 2010 FY | 297.56 Million SEK | 8.35% |
| 2010 Q4 | 81.03 Million SEK | 19.43% |
| 2010 Q3 | 67.84 Million SEK | -7.58% |
| 2010 Q2 | 73.4 Million SEK | -2.48% |
| 2010 Q1 | 75.27 Million SEK | 11.76% |
| 2009 Q4 | 67.35 Million SEK | 3.24% |
| 2009 Q2 | 70.17 Million SEK | 0.0% |
| 2009 FY | 274.62 Million SEK | 21.98% |
| 2009 Q3 | 65.24 Million SEK | -7.03% |
| 2008 FY | 225.14 Million SEK | 19.16% |
| 2007 FY | 188.93 Million SEK | 10.32% |
| 2006 FY | 171.26 Million SEK | 42.58% |
| 2005 FY | 120.12 Million SEK | 15.66% |
| 2004 FY | 103.85 Million SEK | 7.89% |
| 2003 FY | 96.25 Million SEK | -6.8% |
| 2002 FY | 103.28 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Heart Tronics, Inc. | - USD | -Infinity% |
| Lombard Medical, Inc. | 12.16 Million USD | -28760.219% |
| Hamilton Thorne Ltd. | 68.45 Million USD | -5030.129% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -347.0% |
| QHSLab, Inc. | 1.4 Million USD | -249155.675% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -1723851.737% |
| BrainsWay Ltd. | 31.78 Million USD | -10949.237% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -260278.052% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Theraclion SA | 1.82 Million USD | -192631.837% |
| Avitar, Inc. | 3.1 Million USD | -112963.029% |
| AVITA Medical, Inc. | 50.56 Million USD | -6846.064% |
| Aurora Spine Corporation | 14.52 Million USD | -24086.602% |
| SS Innovations International, Inc. | 5.87 Million USD | -59630.837% |
| Nanomix Corporation | 15.45 Thousand USD | -22731291.586% |
| CVR Medical Corp. | - USD | -Infinity% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -347.0% |
| BioElectronics Corporation | 714.7 Thousand USD | -491289.491% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -4054859.012% |
| Stratec SE | 289.14 Million USD | -1114.599% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | -6575.41% |
| Escalon Medical Corp. | 11.98 Million USD | -29211.834% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -487218.886% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -3583573.469% |
| Polarean Imaging plc | 890.93 Thousand USD | -394093.503% |
| NewCardio, Inc. | 257.39 Thousand USD | -1364318.665% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -123333.186% |
| Vivos Inc. | 19.5 Thousand USD | -18010156.41% |
| Kelyniam Global, Inc. | 2.67 Million USD | -131319.567% |
| MicroPort Scientific Corporation | 950.72 Million USD | -269.402% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -4156900.142% |
| VMS Rehab Systems, Inc. | 71.70 USD | -4898186789.819% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -124554.556% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -530774.461% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Positron Corporation | 734.66 Thousand USD | -477940.361% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| ALR Technologies Inc. | 7468.00 USD | -47027216.551% |
| Vycor Medical, Inc. | 1.46 Million USD | -240348.472% |
| SANUWAVE Health, Inc. | 20.39 Million USD | -17117.374% |
| IR-Med Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -870212.961% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| Urologix, Inc. | 14.23 Million USD | -24571.584% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -106234.825% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -8741654.823% |
| Smith & Nephew plc | 5.68 Billion USD | 38.198% |
| NIOX Group Plc | 46.84 Million USD | -7396.841% |
| Fuse Medical, Inc. | 16.11 Million USD | -21692.707% |
| Broncus Holding Corporation | 10.25 Million USD | -34146.709% |
| Brain Scientific Inc. | 214.56 Thousand USD | -1636707.666% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -177474.361% |
| Health Logic Interactive Inc. | - USD | -Infinity% |